Literature DB >> 29120563

Diagnosing and managing mild cognitive impairment.

Sophie Behrman, Vyara Valkanova, Charlotte L Allan.   

Abstract

There has been a rapid rise in the number of people diagnosed with dementia in England from 232,000 in 2008 to 850,000 in 2014. Currently, it is estimated that the prevalence of mild cognitive impairment in adults aged 65 and over is 10-20%. It is likely that this figure will increase in line with trends in dementia diagnosis. In some cases, mild cognitive impairment may be a prodrome for dementia, and my be caused by any of the dementia pathology subtypes. The relationship between depression in the elderly and mild cognitive impairment is difficult to tease out as they are frequently comorbid conditions and both have been found to be independent risk factors for subsequent dementia: about 10% convert to dementia each year, compared with 1-2% of the general elderly population. It is important to obtain a history of cognitive changes over time, as well as information about the onset and nature of cognitive symptoms, confirmed by a reliable informant, if available. To confirm the diagnosis objective evidence of cognitive impairment is required. However, there are no specific neuropsychological tests for patients with mild cognitive impairment. On neuropsychological tests, individuals with mild cognitive impairment typically score 1-15 SD below the mean for their age and education, although these ranges are guidelines and not cut-off scores. GPs should consider referring people who signs of mild cognitive impairment for assessment by specialist memory assessment services to aid early identification of dementia, because more than 50% of people with mild cognitive impairment later develop dementia.

Entities:  

Mesh:

Year:  2017        PMID: 29120563

Source DB:  PubMed          Journal:  Practitioner        ISSN: 0032-6518


  8 in total

1.  Automated assessment of speech production and prediction of MCI in older adults.

Authors:  Victoria Sanborn; Rachel Ostrand; Jeffrey Ciesla; John Gunstad
Journal:  Appl Neuropsychol Adult       Date:  2020-12-30       Impact factor: 2.050

2.  Souvenaid in the management of mild cognitive impairment: an expert consensus opinion.

Authors:  Jeffrey Cummings; Peter Passmore; Bernadette McGuinness; Vincent Mok; Christopher Chen; Sebastiaan Engelborghs; Michael Woodward; Sagrario Manzano; Guillermo Garcia-Ribas; Stefano Cappa; Paulo Bertolucci; Leung-Wing Chu
Journal:  Alzheimers Res Ther       Date:  2019-08-17       Impact factor: 8.823

3.  Expert Consensus on the Care and Management of Patients with Cognitive Impairment in China.

Authors:  Yuliang Han; Jianjun Jia; Xia Li; Yang Lv; Xuan Sun; Shanshan Wang; Yongjun Wang; Zhiwen Wang; Jintao Zhang; Jiong Zhou; Yuying Zhou
Journal:  Neurosci Bull       Date:  2019-12-02       Impact factor: 5.271

4.  Progression in Vascular Cognitive Impairment: Pathogenesis, Neuroimaging Evaluation, and Treatment.

Authors:  Xin Zhang; Jiabin Su; Chao Gao; Wei Ni; Xinjie Gao; Yuxin Li; Jun Zhang; Yu Lei; Yuxiang Gu
Journal:  Cell Transplant       Date:  2018-11-29       Impact factor: 4.139

5.  Neurogranin as a cognitive biomarker in cerebrospinal fluid and blood exosomes for Alzheimer's disease and mild cognitive impairment.

Authors:  Weilin Liu; Huawei Lin; Xiaojun He; Lewen Chen; Yaling Dai; Weiwei Jia; Xiehua Xue; Jing Tao; Lidian Chen
Journal:  Transl Psychiatry       Date:  2020-04-29       Impact factor: 7.989

6.  The Efficacy of Cognitive Training for Elderly Chinese Individuals with Mild Cognitive Impairment.

Authors:  Zhenren Peng; Hu Jiang; Xiaomin Wang; Kaiyong Huang; Yukun Zuo; Xiangmin Wu; Abu S Abdullah; Li Yang
Journal:  Biomed Res Int       Date:  2019-11-30       Impact factor: 3.246

7.  Methylglyoxal and Glyoxal as Potential Peripheral Markers for MCI Diagnosis and Their Effects on the Expression of Neurotrophic, Inflammatory and Neurodegenerative Factors in Neurons and in Neuronal Derived-Extracellular Vesicles.

Authors:  Mohamed Haddad; Morgane Perrotte; Mohamed Raâfet Ben Khedher; Clément Demongin; Aurélie Lepage; Tamás Fülöp; Charles Ramassamy
Journal:  Int J Mol Sci       Date:  2019-10-03       Impact factor: 6.208

8.  A pilot feasibility randomized controlled trial on combining mind-body physical exercise, cognitive training, and nurse-led risk factor modification to reduce cognitive decline among older adults with mild cognitive impairment in primary care.

Authors:  Zijun Xu; Dexing Zhang; Allen T C Lee; Regina W S Sit; Carmen Wong; Eric K P Lee; Benjamin H K Yip; Jennifer Y S Tiu; Linda C W Lam; Samuel Y S Wong
Journal:  PeerJ       Date:  2020-09-07       Impact factor: 3.061

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.